As typically and commonly used cytotoxic drugs in the treatment of breast cancer, paclitaxel (PTX, a microtubule-stabilizing drug) and doxorubicin (DOX, a DNA damaging drug) can both enhance the P-gp expression and induce MDR, resulting in the failure of chemotherapy [7]. Here, PGP is linked to breast cancer.